Quest Diagnostics Inc (NYSE:DGX) over-valued by 12%
Website | https://www.questdiagnostics.com/ |
Sector | Healthcare |
Industry | Diagnostics & Research |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $15,887,460,352 |
Beta | 1.033645 |
Average Volume | $1,256,940 |
Last Dividend | 2.3% |
Price on Jul 22, 2022 | $140.57 |
Autochartist™ Valuation | $123.37 |
Conclusion |
12% over-valued |
Download Report |